☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - August 2012

The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines.

Rifaximin (Xifaxanta®) has been rejected for the treatment of travellers' diarrhoea that is not associated with fever, bloody diarrhoea, 8 or more unformed stools in the previous 24 hours or occult blood or leucocytes in the stool. The manufacturer failed to make a submission.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - August 2012' by emailShare 'SMC Update - August 2012' on FacebookShare 'SMC Update - August 2012' on TwitterShare 'SMC Update - August 2012' on LinkedInShare 'SMC Update - August 2012' on reddit


No Comments to “SMC Update - August 2012”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.